drugset / Trial / NCT01621113
Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury
Phase 2
Completed
27 enrolled
Kessler Foundation
Acorda Therapeutics · collabNational Institute on Disability, Independent Living, and Rehabilitation Research · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the efficacy, safety, and tolerability of treatment with dalfampridine in combination with locomotor training in persons with chronic, motor incomplete SCI.
Timeline
- Start
- 2012-06
- Primary completion
- 2017-10-09
- Completion
- 2017-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalfampridine | Unknown | 10 mg | — |